26978-1-AP

antibody from Proteintech Group

Targeting: DCDC2 DCDC2A, DFNB66, KIAA1154, NPHP19, RU2

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

26978-1-AP

Provider

Proteintech Group

Product name

DCDC2 antibody

Antibody type

Polyclonal

Description

DCDC2 antibody (Cat. #26978-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma.

Xu Q, Chen H, Wang G, Wang X, Shi J, Cheng Y, Xu Y, Ma S, Guo S, Liu X, Gao Q, Song G
Cancer letters 2026 May 28;646:218393

---

TAK1 inhibition mitigates intracerebral hemorrhage-induced brain injury through reduction of oxidative stress and neuronal pyroptosis via the NRF2 signaling pathway.

Zhao J, Chen C, Ge L, Jiang Z, Hu Z, Yin L
Frontiers in immunology 2024;15:1386780

---

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl(4)-induced liver fibrosis by suppressing Wnt/β-catenin signaling.

Liu QQ, Chen J, Ma T, Huang W, Lu CH
Scientific reports 2024 Apr 24;14(1):9425

---

Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.

Jung HJ, Dixon EE, Coleman R, Watnick T, Reiter JF, Outeda P, Cebotaru V, Woodward OM, Welling PA
Physiological genomics 2023 Nov 1;55(11):565-577